San Francisco, CA – [November 15, 2022] — Carta Healthcare®, provider of solutions for common healthcare data challenges through a combination of people, processes, and technology, today announced that the organization is one of only a handful of registry vendors to become a certified software vendor for the Society of Thoracic Surgeons (STS) / American College of Cardiology (ACC)® Transcatheter Valve Therapy (TVT) Registry™. This comes on the heels of a successful $20M Series B fundraising round.
“According to data from the TVT registry, the use of transcatheter aortic valve replacement (TAVR) procedures has outpaced that of surgical aortic valve replacement (SAVR) due to promising patient outcomes,” said Matt Hollingsworth, CEO and Co-founder of Carta Healthcare. “Cardiologists are able to understand and monitor these outcomes thanks to the TVT Registry. We’re excited to be able to contribute to the registry using Atlas, our automated data abstraction solution that greatly improves the ease, speed, and accuracy of extracting data from medical records for registry submission.”
A collaboration between the STS and ACC, the STS/ACC TVT Registry provides a means to monitor real-world patient outcomes, including safety and effectiveness, related to transcatheter valve replacement and repair procedures. Participation in the TVT Registry satisfies recent requirements enacted by the Centers for Medicare and Medicaid Services (CMS) for reimbursement of TAVR and transcatheter mitral valve repair (TMVR) procedures.
Atlas, Carta Healthcare’s data abstraction solution, allows hospitals to free up clinical staff by optimizing the ease, speed, and accuracy by which hospitals can get their data out of medical records and into the TVT registry. Atlas helps capture the necessary historical information for the initial procedure, 30-day follow-up, and one-year follow-up visits to meet the registry requirements, replacing traditional spreadsheet-based processes. The solution provides an easy way for registry submission teams to easily monitor if follow-ups are completed or outstanding. Additionally, Atlas’ industry-leading inter-relator reliability (IRR) scores provide confidence that data are accurate and trustworthy for value-based care reimbursement models as well as research and quality initiatives.
To learn more about how Carta Healthcare’s Atlas can optimize registry participation and free up clinicians so they can spend more time focusing on patient care and research initiatives, watch the overview video here or visit www.carta.healthcare.
Founded in 2017, Carta Healthcare’s mission is to improve patient care by harnessing the value of clinical data. Through its combination of industry-leading, AI-driven technology, and multidisciplinary team of experts, Carta Healthcare has transformed the traditional clinical data abstraction process. The company’s agile, innovative approach to expertise and technology allows healthcare organizations to collect, analyze, and act on their clinical and operational data in a fraction of the time. The result is high-quality, accurate, trustworthy datasets for use across a healthcare organization’s initiatives to operate more efficiently, optimize care delivery, improve patient outcomes, and allow clinicians to practice at the top of their license. For more information, check out our new podcast, Charting the Waters; visit www.carta.healthcare; or contact us at hello@carta.healthcare.
Katlyn Nesvold
Amendola Communications for Carta Healthcare
knesvold@acmarketingpr.com
